Follow
julien Taieb
julien Taieb
professor of medecine Hopital Europeen Georges Pompidou, Université de Paris (Paris-Descartes
Verified email at egp.aphp.fr
Title
Cited by
Cited by
Year
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
33912016
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial
C Louvet, R Labianca, P Hammel, G Lledo, MG Zampino, T André, ...
Journal of Clinical Oncology 23 (15), 3509-3516, 2005
12532005
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
F Ghiringhelli, C Ménard, M Terme, C Flament, J Taieb, N Chaput, ...
The Journal of experimental medicine 202 (8), 1075-1085, 2005
11892005
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
T Voron, O Colussi, E Marcheteau, S Pernot, M Nizard, AL Pointet, ...
Journal of Experimental Medicine 212 (2), 139-148, 2015
9852015
Duration of adjuvant chemotherapy for stage III colon cancer
A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ...
New England Journal of Medicine 378 (13), 1177-1188, 2018
8982018
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ...
The Lancet Oncology 17 (6), 801-810, 2016
8852016
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma …
V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ...
The Lancet Oncology 18 (12), 1624-1636, 2017
7622017
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G Argilés, J Tabernero, R Labianca, D Hochhauser, R Salazar, T Iveson, ...
Annals of Oncology 31 (10), 1291-1305, 2020
7372020
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer
M Terme, S Pernot, E Marcheteau, F Sandoval, N Benhamouda, ...
Cancer research 73 (2), 539-549, 2013
6352013
A novel dendritic cell subset involved in tumor immunosurveillance
J Taieb, N Chaput, C Ménard, L Apetoh, E Ullrich, M Bonmort, ...
Nature medicine 12 (2), 214-219, 2006
5332006
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction …
YJ Bang, EY Ruiz, E Van Cutsem, KW Lee, L Wyrwicz, M Schenker, ...
Annals of Oncology 29 (10), 2052-2060, 2018
4742018
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Rα
S Viaud, M Terme, C Flament, J Taieb, F André, S Novault, B Escudier, ...
PloS one 4 (3), e4942, 2009
4442009
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A Cervantes, R Adam, S Roselló, D Arnold, N Normanno, J Taïeb, ...
Annals of Oncology 34 (1), 10-32, 2023
4002023
SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation …
GA Van Hazel, V Heinemann, NK Sharma, M Peeters
Journal of clinical oncology.-New York 34 (15), 1723-1731, 2016
3922016
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
3662017
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with …
E Tartour, H Pere, B Maillere, M Terme, N Merillon, J Taieb, F Sandoval, ...
Cancer and Metastasis Reviews 30, 83-95, 2011
3602011
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects
C Borg, M Terme, J Taïeb, C Ménard, C Flament, C Robert, K Maruyama, ...
The journal of clinical investigation 114 (3), 379-388, 2004
3582004
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection
N Chaput, NEC Schartz, F André, J Taïeb, S Novault, P Bonnaventure, ...
The Journal of Immunology 172 (4), 2137-2146, 2004
3502004
Control of the immune response by pro-angiogenic factors
T Voron, E Marcheteau, S Pernot, O Colussi, E Tartour, J Taieb, M Terme
Frontiers in oncology 4, 70, 2014
3342014
Identification of CD8+ CD25+ Foxp3+ suppressive T cells in colorectal cancer tissue
N Chaput, S Louafi, A Bardier, F Charlotte, JC Vaillant, F Ménégaux, ...
Gut 58 (4), 520-529, 2009
3332009
The system can't perform the operation now. Try again later.
Articles 1–20